Bioventus Spin-out Creates New Leader In Orthobiologics
By
Tom Salemi / Email the Author / IN VIVO January 2012, Vol. 30, No. 1
Around The Industry / Word Count: 1167 / Article # 2012800013
Executive Summary
The spin-out of Smith & Nephew’s Biologics and Clinical Therapies division into a privately held entity, Bioventus LLC may serve as a model for other large publicly held device companies seeking to maximize the performance of non-core businesses.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.